Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Chrysos Corp. Ltd. ( (AU:C79) ) is now available.
Chrysos Corporation Limited reported a 46% increase in revenue to $66.1 million for the year ending June 30, 2025, driven primarily by its PhotonAssay™ technology. Despite the revenue growth, the company experienced a significant net loss of $8.2 million, attributed to increased expenses in various areas including employee benefits, IT, and finance costs. This financial performance indicates challenges in managing operational costs despite strong market demand for its products.
The most recent analyst rating on (AU:C79) stock is a Hold with a A$6.70 price target. To see the full list of analyst forecasts on Chrysos Corp. Ltd. stock, see the AU:C79 Stock Forecast page.
More about Chrysos Corp. Ltd.
Chrysos Corporation Limited operates in the technology industry, focusing on providing innovative assay solutions. The company’s primary product, PhotonAssay™, is a cutting-edge technology used for analyzing gold and other metals, which has seen significant revenue growth.
Average Trading Volume: 212,810
Technical Sentiment Signal: Buy
Current Market Cap: A$785.1M
For an in-depth examination of C79 stock, go to TipRanks’ Overview page.